CN Patent
CN103126986A — 一种丁酸氯维地平静脉注射用乳剂及其制备方法
Assigned to Individual · Expires 2013-06-05 · 13y expired
What this patent protects
本发明公开了一种丁酸氯维地平静脉注射用乳剂及其制备方法,包括以下组分:丁酸氯维地平0.5mg/mL,精制大豆油200mg/mL,高纯度卵磷脂12mg/mL,油酸0.3mg/mL,甘油22.5mg/mL,EDTA-2Na0.05mg/mL。每瓶乳剂中活性成分丁酸氯维地平0.5mg/mL或1.0mg/mL。
USPTO Abstract
本发明公开了一种丁酸氯维地平静脉注射用乳剂及其制备方法,包括以下组分:丁酸氯维地平0.5mg/mL,精制大豆油200mg/mL,高纯度卵磷脂12mg/mL,油酸0.3mg/mL,甘油22.5mg/mL,EDTA-2Na0.05mg/mL。每瓶乳剂中活性成分丁酸氯维地平0.5mg/mL或1.0mg/mL。
Drugs covered by this patent
- Cleviprex (CLEVIDIPINE) · Chiesi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.